欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0713/002
药品名称
Symamis
活性成分
amisulpride 100.0 mg
剂型
Tablet
上市许可持有人
Symphar Sp. z o.o. Koszykowa 65 00-667 Warsaw Poland
参考成员国 - 产品名称
Poland (PL)
互认成员国 - 产品名称
许可日期
2019/04/17
最近更新日期
2023/06/27
药物ATC编码
N05AL05 amisulpride
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
DK_H_2876_001_004_DC _ common_labelling_combined _ seq 0000
Date of last change:2024/09/06
Final Product Information
|
DK_H_2876_001_004_DC _ common_pil_combined_clean _ seq 0002
Date of last change:2024/09/06
Final Product Information
|
DK_H_2876_001_004_DC _ common_spc_combined_clean _ seq 0002
Date of last change:2024/09/06
PubAR
|
PAR _ Amisulpride _ DK_H_2876_001_004_DC
Date of last change:2024/09/06
PubAR Summary
|
sPAR _ Amisulpride _ DK_H_2876_001_004_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase